The Latent Period Before the Onset of Acute Rheumatic Fever † by Rammelkamp, Charles H. & Stolzer, Bertrand L.
Streptococcal Disease Laboratory,
Francis E. Warren Air Force Base,
CHARLES H. RAMMELKAMP, JR.* Wyoming, and the Departments of
BERTRAND L. STOLZER** Preventive Medicine and Medicine, Western Reserve University School
of Medicine, Cleveland, Ohio
THE LATENT PERIOD BEFORE THE ONSET OF
ACUTE RHEUMATIC FEVERt
INTRODUCTION
John R. Paul has been interested in the latent period and the incubation
period of a variety of infectious diseases because careful study of the host
during these periods frequently yields important clues concerning
pathogenesis. In the case of rheumatic fever, the latent period begins
at the onset of symptoms of the acute group A streptococcal respiratory
infection and ends at the time of development of symptoms of acute rheu-
matic fever. Thus, in the early phase of the latent period, the patient
exhibits signs and symptoms of tonsillitis or pharyngitis, whereas in the
second phase, unless a suppurative complication supervenes, the patient is
asymptomatic.1
The occurrence of a latent period prior to the development of symptoms
of acute rheumatic fever or acute glomerulonephritis is responsible for
the suggestion that these two complications of group A streptococcal in-
fections represent some form of altered tissue reactivity of an immunological
nature."8 Ranz, Boisvert, and Spink' studied a group of patients during
the latent period and suggested, on the basis of bacteriologic studies, that
reinfection with a new type of streptococcus may be necessary for the
development of these non-suppurative complications. In order to define
the normal latent period as well as to determine the effect of reinfection
during this time interval the experience at the Streptococcal Disease Labora-
ory was reviewed. At this facility, all patients with clinically evident
streptococcal disease or acute rheumatic fever were hospitalized and studied
by standard methods including bacteriologic and serologic techniques.
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Thus, it was possible to define the latent period and to examine some of the
factors which might be expected to alter its length.
METHODS
The records of all airmen admitted to the hospital at Francis E. Warren Air Force
Base between January 1949 and June 1953 with symptoms of acute rheumatic fever
were studied. A final diagnosis of acute rheumatic fever was made utilizing the criteria
of Jones' with slight modification.6
During the same period that the patients with acute rheumatic fever were observed,
all airmen with symptoms of an acute respiratory illness associated with either fever
or exudative tonsillitis or pharyngitis were admitted to a special study unit. After a
history, physical examination, oropharyngeal culture and an acute phase serum speci-
men were obtained, half of the patients received therapy with an antibiotic and the
remaining patients were given symptomatic therapy and served as controls. These
TABLE 1. PATIENTS WITH AcuiE RHEUMATIc FEVER INCLUDED IN STUDY
Category Number Per cent
Acute rheumatic fever 565 100
Observed during preceding infection 274 48
Date of onset of rheumatic fever not known 23 4
Total analyzed 251 44
studies were designed to determine the effectiveness of various thrapeutic regimens in
the prevention of acute rheumatic fever. As a part of these investigations each patient
was carefully observed during convalescence to determine whether complications de-
veloped. A second culture of the oropharynx and a specimen of serum were obtained
approximately three weeks after the onset of the streptococcal illness. If the patient
developed rheumatic fever, additional cultures were taken. In each case an effort was
made to date accurately the onset of symptoms of the streptococcal infection and the
time the first rheumatic symptoms appeared. The period between these two events was
calculated to the nearest day.
The oropharyngeal swabs were rubbed on sheep blood agar plates and after 18-24
hours incubation beta hemolytic colonies were isolated in pure culture. Classification
of these cultures into serologic groups and types was performed by standard pro-
cedures.7 Antistreptolysin 0 titers were determined at the same time on all sera col-
lected from any one patient.
RESULTS
During the period of this study 565 patients exhibiting the classical
features of acute rheumatic fever were observed on the hospital wards
(Table 1). Of these patients, 274 or 48 per cent had been hospitalized
previously because of an acute respiratory illness. Examination of these
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274 records showed that in 23 the dates of onset of the symptoms of
acute rheumatic fever were uncertain, so that the present analysis was
limited to the remaining 251 patients.
Table 2 presents the latent periods of these 251 patients grouped in
intervals of three days. Since prior studies had demonstrated that indi-
TABLE 2. THE LATENT PERIOD OF 251 PATIENTS WITH RHEUMATIC FEVER
OBSERVED DURING A PRECEDING RESPIRATORY INFECTION
Initial culture
Latent Group A streptococcus
period Single Two Received
(days) infectiont infectionst therapy Negative* Totals
0-2 2 0 5 6 13
3-5 3 0 2 0 5
6-8 6 0 4 1 11
9-11 10 1 2 1 14
12-14 16 1 2 3 22
15-17 11 1 4 4 20
18-20 18 2 2 3 25
21-23 15 2 3 1 21
24-26 17 4 2 4 27
27-29 6 3 2 4 15
30-32 5 2 1 1 9
33-35 4 1 1 2 8
36-45 11 15 6 10 42
Over 45 3 6 6 4 19
Totals 127 38 42 44 251
t Convalescent culture was negative or showed the same type isolated on initial
culture.
tA type different than that isolated on the initial culture was identified during
convalescence. Nine of these patients received antibiotics of whom 7 exhibited an
interval of over 35 days.
* Eighteen of these patients subsequently showed a positive culture.
viduals exhibiting long latent periods usually had experienced an inter-
vening streptococcal infection as determined by bacteriologic, serologic
or historical evidence"8 such patients were listed together. Of the entire
group of 251 patients 61 or 24 per cent showed latent periods of over
35 days, and 19 or 8 per cent of the intervals were over 45 days. Based
on bacteriologic studies alone, 21 of these 61 patients with long latent
periods experienced a reinfection, whereas reinfections were demonstrated
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in only 17 of the 190 patients with latent periods of less than 36 days. In
addition, 26 of the patients with long latent periods either showed no group
A streptococci on admission to the hospital for the observed respiratory
illness or they received therapy with an antibiotic. In both instances, it
appeared reasonable to assume that either an inapparent or a continuing
infection with a group A streptococcus probably occurred after the observed
illness and before the onset of rheumatic fever.9 For these reasons it ap-
peared unlikely that most of the cases of acute rheumatic fever with latent
periods of over 35 days were directly precipitated by the observed respira-
tory illness.
TABLE 3. CHARACTERISTICS OF THE PRECEDING RESPIRATORY ILLNESS IN
127 PATIENTS WHO RECEIVED No SPECIFIC THERAPY AND WHO
SHOWED No BACTERIOLOGIC EVIDENcE OF REINF:ECTION PRIOR TO
ONSET OF RHEUMATIC FEVER
Number Per cent
Observed Present present
Exudate 127 98 78
Increase in antistreptolysin titer 118 109 92
Leukocytosis of 12,000 or greater 119 109 92
Since these studies were conducted in a population experiencing epi-
demics of streptococcal and non-streptococcal respiratory diseases, it
was essential to establish the etiology of the observed respiratory illnesses.
In addition, it was assumed that specific antistreptococcal therapy of the
observed illness or the occurrence of a new, inapparent, streptococcal in-
fection prior to the onset of rheumatic symptoms might affect the length
of the latent period. Thus, the 251 patients seleced for analysis were
subdivided into the various groups presented in Table 2.
There were 127 patients who showed group A streptococci from the
culture obtained on hospitalization, who received no specific therapy with
antibiotics or sulfonamide drugs, and whose convalescent cultures were
either negative or showed the infetcing type of streptococcus. The data
presented in Table 3 document the fact that the observed respiratory ill-
nesses in these patients were caused by the streptococcus. The majority of
the patients was found to have an exudative lesion of the pharynx or
tonsils and elevation of the total leukocyte count. As many as 92 per cent
exhibited a significant increase in the titer of antistreptolysin during con-
valescence.
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The distribution of the latent periods observed in these 127 patients
is shown in Figure 1 as well as in Table 2. In this group the latent period
was greater than 35 days in only 14 or 11 per cent. In 3 patients the
latent period was over 45 days. Although bacteriologic evidence of re-
infection was lacking in these 14 patients, it seems probable that most
had experienced a new, unobserved infection which was not detected by
the bacteriologic technique employed. In contrast, the majority of the re-
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FIG. 1. The latent period in acute rheumatic fever.
maining 113 observed illnesses probably represent infection by a single
serologic type.
The mean interval for those patients exhibiting a latent period of less
than 36 days was 18.6 days; the median was 19 days. The frequency
distribution of the latent periods roughly parallels a normal distribution
curve. This is especially true if those patients who have experienced a
prior attack of rheumatic fever, as depicted in Figure 1, are eliminated
from consideration. The 21 individuals who were experiencing a recurrent
attack of rheumatic fever did not exhibit a shortened latent period, nor
did any show a latent period of over 35 days.
Of the 113 patients with latent periods of less than 36 days, 11 or 10
per cent, developed rheumatic symptoms during the first 8 days. There
were 2 patients whose symptoms of acute rheumatic fever appeared to
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develop near the time of onset of the acute respiratory illness. In one
the initial antistreptolysin titer was 500 indicating that this patient had
recently experienced another streptococcal infection which may have ac-
counted for the apparent short latent period. However, he had no recol-
lection of a recent sore throat prior to the observed illness and examination
showed no exudate on the tonsils or pharynx. It is possible that the
symptom, sore throat, was associated with the onset of acute rheumatic
TABLE 4. AVERAGE LATENT PERIOD AccoRDING TO THE TYPE
OF GROUP A STRpETococcus CAUSING THE INFECTION
Average interval
Type of streptococcus (days) Number of patients*
14 19 52
5 20 19
30 17 10
19 17 8
24 15 6
18 21 5
NT 22 5
1 13 3
3 12 3
6 21 1
4 24 1
* Limited to the 113 patients who received no therapy and showed no evidence of
reinfection. The 14 patients with intervals greater than 35 days are omitted.
fever and did not represent a new respiratory illness. The second patient
exhibited exudative pharyngitis and the initial antistreptolysin titer was
125 which later increased to 250 units. He gave no history of a prior respira-
tory illness. Thus, in this patient the rheumatic symptoms appeared without
a latent period.
The relationship of the length of the latent period to the type of infecting
organism is presented in Table 4. There were 10 different types causing
the initial infection in addition to the 5 patients from whom a non-typable
strain was isolated. The majority of infections was due to type 14. The
relative frequency of the types isolated paralleled the frequency with which
these types were present in other patients with strptococcal pharyngitis
who did not develop rheumatic fever. The length of the latent period did not
appear to be a function of any particular type.
The relationship of the latent period to the titer of antistreptolysin in
the acute phase sera as well as to the average increase in titer demon-
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strated during convalescence is shown in Table 5. No definite conclusion
can be made regarding the average initial titers or the average increase
in titers in those patients with short or long latent periods. It is possible
that the slightly higher average initial titers exhibited by the 5 patients
in the 0-5 day interval is due to the fact that these patients had already ex-
perienced an increase in antibody at the time the initial, acute phase sera
were obtained. This suggestion is confirmed by the relatively small in-
TABLE 5. THE RELATIONSHIP OF THE LATENT PERIOD TO
ANTISTREPTOLYSIN TITERS
Average antistreptolysin titer
Latent period Increaseat
(days) Number of patients* Initial 3 weeks
0-2 2 313 125
3-5 3 187 51
6-8 5 99 336
9-11 8 137 492
12-14 16 173 332
15-17 11 100 256
18-20 18 109 409
21-23 14 136 240
24-26 16 119 208
27-29 5 142 228
30-32 5 175 233
33-35 4 96 263
Greater than 35 11 150 471
*Includes only those patients with acute and convalescent sera who had experienced
a single infection and who received no specific therapy.
crease in antistreptolysin demonstrated in the convalescent sera. Thus,
some of these 5 patients must have acquired a streptococcal infection at
least one week prior to the observed illness. Since the numbers of patients
in each time interval were small, the 107 patients with intervals of 35
days or less were divided into two groups, one with initial antistreptolysin
titers of 200 units or greater and the other with titers of less than 200 units.
The avereage latent period for the group with initial titers above 200
units was 16 days. The average period of the group with initial titer
below 200 was 19 days, a differenece which is not significant.
The 38 patients who carried two different serologic types of group A
streptococci did exhibit a different pattern of latent periods than the 127
patients who showed only one type in the two cultures. There were no
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patients with a latent period of less than 8 days. However, for technical
reasons it might have been difficult to establish the presence of two in-
fections within a week of the observed respiratory illness. There was an
increased number of patients with long latent periods; 21 cases or 55
per cent of the total group developed rheumatic fever more than 35 days
after the onset of the observed illness. Of this group of 21 cases with
a prolonged latent period, 7 had received an antibiotic as therapy for
the observed streptococcal infection, whereas only 2 of the remaining 17
cases were given specific treatment. The second, streptococcal infection,
usually inapparent clinically, was probably related directly to the rheumatic
attack and accounted for the prolonged latent period in many of these
patients.
The distribution of the latent periods of individuals who received anti-
biotics but showed no bacteriological evidence of an intervening new
streptococcal infection is considerably different than the intervals exhibited
by those 127 patients who received no therapy. Of the former, 26 per cent,
as compared to 9 per cent of the latter group, exhibited latent periods
of 8 days or less. The antistreptolysin titers of the acute phase sera from
the 5 patients developing rheumatic fever at about the same time as the
streptococcal respiratory illness began were 83, 83, 250, 317, and 625
indicating that in all probability 2 or 3 patients had recently experienced a
streptococcal infection. Since some patients early in the course of acute
rheumatic fever experience a recurrence of the symptom, soreness of the
throat, it is possible that some of these short latent periods are an
artifact. In addition, it should be recalled that approximately half of all
patients with respiratory infections received antibiotics, so that if therapy
did not alter the incidence of rheumatic fever in those patients who were
destined to develop this complication after a very short latent period,
the actual number observed in this category should approximate the num-
ber observed in the group of 127 patients who experienced a single infection
and received no therapy. The figures show that there were 11 cases in
both groups whose latent period was less than 8 days. Thus, it appears
probable that treatment of the streptococcal infection is not likely to de-
crease the attack rate of rheumatic fever in patients with short latent
periods.
The distribution of the latent periods in those patients whose initial
culture failed to show group A streptococci is difficult to explain. Of the
6 patients developing rheumatic fever during the first time interval, strep-
tococci were isolated from 4 a few days later. The initial antistreptolysin
titer was available from 5 of the 6 patients. In 3 it was 83, and the re-
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maining initial titers were 100 and 250. Of the total group 18 showed
a positive culture during the latent period. Some of these acquisitions
probably represent a new infection, accounting for the relatively large
number of patients with long latent periods.
DISCUSSION
Our concept of the latent period in acute rheumatic fever has been
derived from historical information obtained from the patient at the time
the rheumatic symptoms appeared rather than from observations of
patients with streptococcal infections who subsequently developed signs
of rheumatic activity. Data obtained by the former method tend to be
inaccurate since the memory of the patient concerning events occurring
several weeks earlier is frequently poor, and the etiology of the preceding
respiratory illness cannot be defined. In addition, the studies of Rantz,
Boisvert and Spink' indicate that reinfection with a second type of group
A streptococcus may occur during the latent period without associated
overt clinical symptoms. Further errors are likely to occur because at
least 14 per cent of patients with acute rheumatic fever give no history
of a preceding illness and in another 24 per cent the streptococcal illness
is so mild that the details are soon forgotten.10
In the population of 565 patients with acute rheumatic fever 48 per
cent had been observed previously with an acute respiratory illness of
sufficient severity to require hospitalization. In all but 23 an accurate
history of the time of onsets of the streptococcal infection and rheumatic
fever were obtained. Since routine cultures were obtained at the begin-
ning of the respiratory illness, again three weeks later, and at the time
of appearance of acute rheumatic fever, reinfections with new types of
streptococci could be documented. Thus, it was possible to gain an accurate
description of the latent period in a large group of patients. Such data
provide information of both theoretical and practical value.
The normal distribution curve of the duration of the latent periods was
based on 127 patients who received no therapy. The majority was thought
to have experienced a single preceding streptococcal infection as determined
by routine bacteriological studies. It was recognized that a few patients
exhibiting a very short latent period may have actually acquired a
clinically inapparent-infection some weeks prior to the observed respiratory
illness, and the observed illness actually represented the recurrence of
sore throat which some patients with acute rheumatic fever experience.
In favor of this interpretation is the high titer of antistreptolysin in the
acute phase serum of some patients showing a short latent period. In
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addition, it appeared reasonable to assume that the majority of patients
who exhibited a latent period of over 35 days probably had experienced a
second, clinically inapparent streptococcal infection which was not de-
tected by the techniques employed.
The length of the latent period did not appear to be related to the type
of streptococcus responsible for the respiratory illness nor did it appear
to vary with the magnitude of the antibody response to infection as
measured by antistreptolysin. There was a slight difference in the average
latent periods of those patients with an initial antistreptolysin titer of
less than 200 units and those with greater than 200 units. The average
periods were 19 and 16 days, respectively. This difference may have
been produced by a few patients who had experienced an inapparent
streptococcal infection a few days or weeks prior to the observed illness.
Thus, the initial antistreptolysin titer would be high and the latent period
short in such patients. Since the difference in the latent periods between
the two groups was not great, it may be concluded that few such cases
were included in this analysis.
Of the 127 patients, 21 were experiencing a recurrent attack of acute
rheumatic fever, and in these there was no indication that the latent
period was shortenend. It has been reported that recurrent attacks are not
associated with shorter latent periods' but no published data are avail-
able to support such a statement. More extensive information on this
subject would be valuable since rheumatic fever has been compared to
serum sickness in which the readministration of the responsible antigen
results in an accelerated reaction.
As indicated earlier, Rantz, Boisvert and Spink4 suggested that rein-
fection with a new serological type during the latent period might be
causally related to the development of acute rheumatic fever. The present
analysis does not permit a comparison of attack rates in patients with
one and two infections. However, some information is available from a
study of reinfections in 5198 patients with streptococcal infections ob-
served at the same military installation between January 1949 and January
19548 All of these patients received antibiotics and only a single convalescent
culture was obtained from each. The incidence of reinfection was 10 per
cent, whereas in the present study 15 per cent of the patients with rheumatic
fever showed two organisms during the latent period. Reinfections were
especially prevalent among those patients with long latent periods. Indeed,
if only those patients with latent periods of less than 36 days are con-
sidered, 9 per cent experienced a second infection, a figure which is
similar to the 10 per cent figure observed in the population quoted above.
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Thus, the present data do not support the view that two closely spaced
infections play a major role in the causation of rheumatic fever.
The curve showing the distribution of cases of rheumatic fever according
to the length of the latent period should be of practical value to the
pediatrician, internist, and family physician. It is a well established fact
that proper therapy of the streptococcal infection with penicillin will pre-
vent acute rheumatic fever and, presumably rheumatic carditis. Treatment
initiated at the onset of symptoms of the streptococcal infection might be
expected to fail to eliminate those attacks of rheumatic fever that develop
TABLE 6. MAXIMAL POSSIBLE EFFECT OF THERAPY OF STREPTOCOCCAL
INFECTIONS ON THE OCCURRENCE OF RHEUMATIC FEVER AccORDING
TO THE TIME OF INSTITUTION OF TREATMENT
Time therapy instituted*
(days) Per cent reduction of acute rheumatic fevet4
0 98
8 90
14 67
21 42
29 8
* Expressed in days from onset of first symptom of the respiratory illness.
t Calculations are based on the assumption that adequate therapy will prevent all
rheumatic fever except those cases occurring through the second day. Rheumatic fever
developing after 35 days is considered not to be affected by therapy.
in the first two days. This represents approximately 2 per cent of all
rheumatic attacks. The present data as well as those obtained during
the course of another study9 support this conclusion. More important,
however, is the fact that therapy with penicillin will prevent rheumatic fever
even when it is administered after the patient has fully recovered from
the immediate effects of the streptococcal infection. In the only study re-
ported,' penicillin therapy was initiated nine days after the onset of
the acute respiratory illness at a time when the patients were asymptomatic.
The reduction in the attack rate of rheumatic fever in those developing
symptoms between 10 and 35 days was 82 per cent as compared to a control
group of patients.
If the assumption is made that adequate therapy of the streptococccal in-
fection instituted at any time during the latent period will prevent all
subsequent attacks of rheumatic fever except those developing within the
first 2 days and those appearing after an interval of 35 days, then therapy
initiated at the times indicated in Table 6 will reduce the total number of
396
Vol. 34, Dec.-Feb. 196112Latent period in Rheumatic Fever RAMMELKAMP, STOLZER
cases of rheumatic fever by the amounts indicated. These data would
indicate that the physician who makes a diagnosis of a streptococcal in-
fection in one patient should then determine the dates of onset of sore
throat in other household contacts. Those contacts whose respiratory
symptoms developed during the preceding month and who received no
specific therapy during the acute illness should be placed on treatment
with penicillin for the prevention of rheumatic fever. Ideally, oropharyngeal
cultures from all contacts should also be obtained, since some infections
will produce no symptoms and such individuals should receive the benefit
of specific therapy.
SUMMARY
The latent period between the onset of the streptococcal infection and
the onset of acute rheumatic fever was determined in 251 patients. In
113 of these patients an infection by a single type of streptococcus occurred
and the patient received no specific therapy. In this group the mean latent
period was 18.6 days. There was no correlation between the type of group
A streptococcus causing the infection and the length of the latent period.
Patients who had experienced a prior attack of rheumatic fever did not
exhibit an accelerated onset of rheumatic symptoms. The length of the latent
period did not appear to be related to the magnitude of the antistreptolysin
response to infection.
Reinfection with a new type of streptococcus during the latent period
did not prove to be important in the causation of rheumatic fever, but it
was associated with prolongation of the latent period in many instances.
On the basis of this analysis it is recommended that patients with
streptococcal infections should receive therapy with penicillin for the
prevention of rheumatic fever even though the onset of respiratory symp-
toms was as long as four weeks previously.
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